JAMA Network OPEN
Nancy E. Morden, Weiping Zhou, Ziad Obermeyer, Jonathan Skinner
During the first 2 years of the COVID-19 pandemic, inpatient and ambulatory care
declined dramatically. Little is known about prescription drug receipt during this period, particularly
for populations with chronic illness and with high risk of adverse COVID-19 outcomes and decreased
access to care.